Zydus Lifesciences

DCGI approves three COVID vaccines for kids aged above five years

Read more

Zydus announces publication of “Dream-ND” and “Dream-D” phase-III trials of Desidustat in “American Journal of Nephrology”

Read more

Zydus Lifesciences receives final approval from US FDA for Cyanocobalamin injection

Read more

Zydus to supply Sagent’s Caffeine Citrate Oral Solution from Jarod

Read more

‘The Lancet’ publishes phase-III data of ZyCoV-D

Read more

Zydus receives PAS approval from US FDA for Mycophenolate Mofetil for injection

Read more

Zydus receives final approval from US FDA for Colestipol Hydrochloride tablets

Read more

Sentynl Therapeutics and BridgeBio Pharma announce asset purchase agreement for Nulibry

Read more

Zydus receives DCGI approval for Oxemia to treat anaemia in CKD patients

Read more

Cadila Healthcare renamed as Zydus Lifesciences

Read more